Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2018 June;70(3) > Minerva Ginecologica 2018 June;70(3):303-22

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Minerva Ginecologica 2018 June;70(3):303-22

DOI: 10.23736/S0026-4784.17.04063-1

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Teratology of valproic acid: an updated review of the possible mediating mechanisms

Adalisa PONZANO, Gian M. TIBONI

Department of Medicine and Aging Sciences, G. d’Annunzio University of Chieti-Pescara, Chieti, Italy


PDF


Valproic acid (VPA) is an anti-epileptic drug (AED) which is currently being investigated for its potential application in the treatment of several types of cancers, including solid and non-solid tumor. It is well-known that prenatal exposure to VPA largely increases the risk for malformations and other developmental disorders. This review concentrates on clinical and experimental data on congenital anomalies attributed to maternal VPA exposure. Particular emphasis is placed on the potential mechanisms underlying VPA-induced malformations. Although several mechanisms have been suggested, there appears to be no data in the literature in support of a single definitive mechanism for VPA-exposure-related fetal malformations.


KEY WORDS: Valproic acid - Teratogenesis - Teratology

top of page